院前应用 REBOA 治疗危及生命的大出血

IF 16.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Military Medical Research Pub Date : 2023-12-13 DOI:10.1186/s40779-023-00504-5
Xiao-Mei Tian, Wei Hu, Feng-Yong Liu
{"title":"院前应用 REBOA 治疗危及生命的大出血","authors":"Xiao-Mei Tian, Wei Hu, Feng-Yong Liu","doi":"10.1186/s40779-023-00504-5","DOIUrl":null,"url":null,"abstract":"<p>Dear Editor,</p><p>Most battlefield casualties occur prior to the arrival of medical facilities. Uncontrollable hemorrhage accounts for more than 90% of those potentially survivable battlefield casualties [1]. In both military and civilian conditions, non-compressible torso hemorrhage always caused rapid exsanguination and high mortality rates before definitive treatment [2]. More than half of the deaths due to non-compressible torso hemorrhage occur before hospital care can be provided [2]. Therefore, early and rapid pre-hospital hemorrhage control is essential to reduce mortality.</p><p>Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a life-saving procedure for patients with non-compressible hemorrhage and severe hemorrhagic shock [3]. In addition to in-hospital REBOA, urgent REBOA can be rapidly completed in grim pre-hospital situations for patients [4]. Thus, pre-hospital REBOA application for the treatment of life-threatening hemorrhages has attracted increasing attention. In patients who receive timely pre-hospital REBOA treatment, the mortality can be reduced to less than 40% [5]. In this letter, we focus on the pre-hospital application of REBOA for managing life-threatening traumatic hemorrhages in both military and civilian settings.</p><p>REBOA was first introduced by the US Army in the Korean War to treat intraabdominal hemorrhages. With significant improvements in endovascular equipment and techniques, pre-hospital REBOA has attracted renewed clinical interest. Recently, the US Army reported the use of pre-hospital REBOA in treating modern combat casualties [6]. After pre-hospital REBOA treatment, the patients were finally hemodynamically stabilized and safely evacuated without any apparent complications. Furthermore, the Russian Army have also validated the effectiveness of pre-hospital REBOA on the battlefield [7]. When combined with other resuscitation strategies like blood transfusion, pre-hospital REBOA can further enhance survival rates. Therefore, it is evident that pre-hospital REBOA is an effective method for acute care of massive hemorrhage and can be safely performed in the battlefield setting as an emergency treatment option for individuals at risk of cardiovascular failure due to injuries sustained in combat situations. On the battlefield, frontline implementation of REBOA allows temporary hemorrhage control and facilitates timely evacuation to the hospital, thereby reducing mortality rate and improving overall treatment outcomes, simultaneously saving lives among military personnel. This technology is of great significance for military applications and may become an essential skill for military training programs and medical practices in the future.</p><p>In addition to the battlefield environment, pre-hospital REBOA is also suitable for trauma patients in civilian conditions. Uncontrolled hemorrhagic shock or cardiac arrest accounts for a significant percentage of trauma patients. Some of these patients could benefit from pre-hospital REBOA. For patients severely injured from a high drop, REBOA serves as a safe and effective surgical technique that reduces blood loss and stabilizes the patient’s hemodynamic state, allows for longer transport times, and provides an opportunity for definitive hemostasis [8]. Pre-hospital REBOA uses a portable balloon catheter device to perform emergency bleeding control at the scene, rapidly controlling bleeding, maintaining hemodynamic stability, and providing resuscitative support to avoid death from hemorrhagic shock. Postoperative complications such as lower limb ischemia, organ ischemia–reperfusion injury, and aortic dissection occur less frequently. In the future, further standardized training platforms are needed to guide physicians to familiarize themselves with REBOA technology, indications, adverse reactions, and postoperative care.</p><p>In contrast to in-hospital conditions, REBOA performed in the grim pre-hospital environment requires a coordinated emergency health care system with a well-trained and -equipped care team. Given that battlefield or pre-hospital casualties often require evacuation, it is crucial to ensure the establishment of arterial access and successful placement of the arterial sheath. Successful REBOA placement has been reported on a rotary-wing platform [4]. Thus, it is recommended that eligible patients are promptly evacuated while performing REBOA en route during the evacuation period.</p><p>The prompt implementation of REBOA is crucial in the pre-hospital management of traumatic hemorrhage, emphasizing the necessity for expeditious surgical intervention. Previously, prior to initiating REBOA, ultrasonic or digital subtraction angiography should be performed. With improvements in catheterization devices and techniques, the competencies and successful rates of blind performance increased significantly, especially after comprehensive REBOA training. Following team training, the average time to complete the pre-hospital REBOA procedure under ultrasound guidance was 8.5 min [9]. Thus, standardized training and ample experience is imperative to ensure competency in pre-hospital REBOA. Given its favorable success rate, pre-hospital REBOA holds great appeal for both military and civilian conditions.</p><p>In conclusion, pre-hospital REBOA demonstrates promising potential as a temporary and minimally invasive bridge approach for eventual control of non-compressible traumatic hemorrhage. By occluding the aorta, REBOA effectively redistributes cardiac output to vital organs. As revealed so far, pre-hospital REBOA has shown favorable outcomes in controlling non-compressible torso hemorrhage (Fig. 1). The implementation of REBOA and its clinical training courses will improve the efficacy of pre-hospital treatment for life-threatening traumatic hemorrhages, ultimately reducing the loss of life caused by traumatic hemorrhage.</p><figure><figcaption><b data-test=\"figure-caption-text\">Fig. 1</b></figcaption><picture><source srcset=\"//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40779-023-00504-5/MediaObjects/40779_2023_504_Fig1_HTML.png?as=webp\" type=\"image/webp\"/><img alt=\"figure 1\" aria-describedby=\"Fig1\" height=\"640\" loading=\"lazy\" src=\"//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40779-023-00504-5/MediaObjects/40779_2023_504_Fig1_HTML.png\" width=\"685\"/></picture><p>Pre-hospital application of resuscitative endovascular balloon occlusion of the aorta (REBOA) for life-threatening hemorrhage. Non-compressible traumatic hemorrhage could result in massive bleeding and hemorrhage shock. Pre-hospital utilization of REBOA could effectively stop persistent bleeding and prevent hemorrhage shock</p><span>Full size image</span><svg aria-hidden=\"true\" focusable=\"false\" height=\"16\" role=\"img\" width=\"16\"><use xlink:href=\"#icon-eds-i-chevron-right-small\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"></use></svg></figure><p>Not applicable.</p><dl><dt style=\"min-width:50px;\"><dfn>REBOA:</dfn></dt><dd>\n<p>Resuscitative endovascular balloon occlusion of the aorta</p>\n</dd></dl><ol data-track-component=\"outbound reference\"><li data-counter=\"1.\"><p>Eastridge BJ, Holcomb JB, Shackelford S. Outcomes of traumatic hemorrhagic shock and the epidemiology of preventable death from injury. Transfusion. 2019;59(S2):1423–8.</p><p>Article PubMed Google Scholar </p></li><li data-counter=\"2.\"><p>Morrison JJ, Stannard A, Rasmussen TE, Jansen JO, Tai NRM, Midwinter MJ. Injury pattern and mortality of noncompressible torso hemorrhage in UK combat casualties. J Trauma Acute Care Surg. 2013;75(2 Suppl 2):S263–8.</p><p>Article PubMed Google Scholar </p></li><li data-counter=\"3.\"><p>Cralley AL, Vigneshwar N, Moore EE, Dubose J, Brenner ML, Sauaia A, et al. Zone 1 endovascular balloon occlusion of the aorta vs resuscitative thoracotomy for patient resuscitation after severe hemorrhagic shock. JAMA Surg. 2023;158(2):140–50.</p><p>Article PubMed Google Scholar </p></li><li data-counter=\"4.\"><p>Brown SR, Reed DH, Thomas P, Simpson C, Ritchie JD. Successful placement of REBOA in a rotary wing platform within a combat theater: novel indication for partial aortic occlusion. J Spec Oper Med. 2020;20(1):34–6.</p><p>Article PubMed Google Scholar </p></li><li data-counter=\"5.\"><p>Lendrum R, Perkins Z, Chana M, Marsden M, Davenport R, Grier G, et al. Pre-hospital resuscitative endovascular balloon occlusion of the aorta (REBOA) for exsanguinating pelvic haemorrhage. Resuscitation. 2019;135:6–13.</p><p>Article PubMed Google Scholar </p></li><li data-counter=\"6.\"><p>Glaser J, Teeter W, Gerlach T, Nathanial F. Resuscitative endovascular balloon occlusion of the aorta (REBOA) as an adjunct to damage control surgery for combat trauma: a case report of the first REBOA placed in Afghanistan. J Endovasc Resusc Tr. 2017;1(1):58–62.</p><p>Google Scholar </p></li><li data-counter=\"7.\"><p>Reva VA, Petrov AN, Samokhvalov IM. First Russian experience with endovascular balloon occlusion of the aorta in a zone of combat operations. Angiol Sosud Khir. 2020;26(2):61–75.</p><p>Article CAS PubMed Google Scholar </p></li><li data-counter=\"8.\"><p>Sadek S, Lockey DJ, Lendrum RA, Perkins Z, Price J, Davies GE. Resuscitative endovascular balloon occlusion of the aorta (REBOA) in the pre-hospital setting: an additional resuscitation option for uncontrolled catastrophic haemorrhage. Resuscitation. 2016;107:135–8.</p><p>Article PubMed Google Scholar </p></li><li data-counter=\"9.\"><p>Brede JR, Lafrenz T, Kruger AJ, Sovik E, Steffensen T, Kriesi C, et al. Resuscitative endovascular balloon occlusion of the aorta (REBOA) in non-traumatic out-of-hospital cardiac arrest: evaluation of an educational programme. BMJ Open. 2019;9(5):e027980.</p><p>Article PubMed PubMed Central Google Scholar </p></li></ol><p>Download references<svg aria-hidden=\"true\" focusable=\"false\" height=\"16\" role=\"img\" width=\"16\"><use xlink:href=\"#icon-eds-i-download-medium\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"></use></svg></p><p>Not applicable.</p><p>Not applicable.</p><h3>Authors and Affiliations</h3><ol><li><p>Department of Interventional Radiology, Senior Department of Oncology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100039, China</p><p>Xiao-Mei Tian &amp; Feng-Yong Liu</p></li><li><p>Medical School of Chinese PLA, Beijing, 100853, China</p><p>Xiao-Mei Tian &amp; Feng-Yong Liu</p></li><li><p>Department of Emergency, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100039, China</p><p>Wei Hu</p></li><li><p>Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, 100039, China</p><p>Wei Hu</p></li></ol><span>Authors</span><ol><li><span>Xiao-Mei Tian</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Wei Hu</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Feng-Yong Liu</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li></ol><h3>Contributions</h3><p>FYL and WH conceived the study and supervised the work performed. XMT and WH wrote the manuscript. XMT and WH constructed the figure. FYL edited the manuscript and provided comments and feedback. All authors read and approved the final manuscript.</p><h3>Corresponding authors</h3><p>Correspondence to Wei Hu or Feng-Yong Liu.</p><h3>Ethics approval and consent to participate</h3>\n<p>Not applicable.</p>\n<h3>Consent for publication</h3>\n<p>Not applicable.</p>\n<h3>Competing interests</h3>\n<p>The authors declare no competing interests.</p><p><b>Open Access</b> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</p>\n<p>Reprints and Permissions</p><img alt=\"Check for updates. Verify currency and authenticity via CrossMark\" height=\"81\" src=\"data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg>\" width=\"57\"/><h3>Cite this article</h3><p>Tian, XM., Hu, W. &amp; Liu, FY. Pre-hospital application of REBOA for life-threatening hemorrhage. <i>Military Med Res</i> <b>10</b>, 65 (2023). https://doi.org/10.1186/s40779-023-00504-5</p><p>Download citation<svg aria-hidden=\"true\" focusable=\"false\" height=\"16\" role=\"img\" width=\"16\"><use xlink:href=\"#icon-eds-i-download-medium\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"></use></svg></p><ul data-test=\"publication-history\"><li><p>Received<span>: </span><span><time datetime=\"2023-11-26\">26 November 2023</time></span></p></li><li><p>Accepted<span>: </span><span><time datetime=\"2023-12-02\">02 December 2023</time></span></p></li><li><p>Published<span>: </span><span><time datetime=\"2023-12-13\">13 December 2023</time></span></p></li><li><p>DOI</abbr><span>: </span><span>https://doi.org/10.1186/s40779-023-00504-5</span></p></li></ul><h3>Share this article</h3><p>Anyone you share the following link with will be able to read this content:</p><button data-track=\"click\" data-track-action=\"get shareable link\" data-track-external=\"\" data-track-label=\"button\" type=\"button\">Get shareable link</button><p>Sorry, a shareable link is not currently available for this article.</p><p data-track=\"click\" data-track-action=\"select share url\" data-track-label=\"button\"></p><button data-track=\"click\" data-track-action=\"copy share url\" data-track-external=\"\" data-track-label=\"button\" type=\"button\">Copy to clipboard</button><p> Provided by the Springer Nature SharedIt content-sharing initiative </p><h3>Keywords</h3><ul><li><span>Resuscitative endovascular balloon occlusion of the aorta (REBOA)</span></li><li><span>Pre-hospital</span></li><li><span>Endovascular</span></li><li><span>Aortic balloon occlusion</span></li><li><span>Trauma</span></li><li><span>Hemorrhage</span></li><li><span>Shock</span></li></ul>","PeriodicalId":18581,"journal":{"name":"Military Medical Research","volume":null,"pages":null},"PeriodicalIF":16.7000,"publicationDate":"2023-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pre-hospital application of REBOA for life-threatening hemorrhage\",\"authors\":\"Xiao-Mei Tian, Wei Hu, Feng-Yong Liu\",\"doi\":\"10.1186/s40779-023-00504-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Dear Editor,</p><p>Most battlefield casualties occur prior to the arrival of medical facilities. Uncontrollable hemorrhage accounts for more than 90% of those potentially survivable battlefield casualties [1]. In both military and civilian conditions, non-compressible torso hemorrhage always caused rapid exsanguination and high mortality rates before definitive treatment [2]. More than half of the deaths due to non-compressible torso hemorrhage occur before hospital care can be provided [2]. Therefore, early and rapid pre-hospital hemorrhage control is essential to reduce mortality.</p><p>Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a life-saving procedure for patients with non-compressible hemorrhage and severe hemorrhagic shock [3]. In addition to in-hospital REBOA, urgent REBOA can be rapidly completed in grim pre-hospital situations for patients [4]. Thus, pre-hospital REBOA application for the treatment of life-threatening hemorrhages has attracted increasing attention. In patients who receive timely pre-hospital REBOA treatment, the mortality can be reduced to less than 40% [5]. In this letter, we focus on the pre-hospital application of REBOA for managing life-threatening traumatic hemorrhages in both military and civilian settings.</p><p>REBOA was first introduced by the US Army in the Korean War to treat intraabdominal hemorrhages. With significant improvements in endovascular equipment and techniques, pre-hospital REBOA has attracted renewed clinical interest. Recently, the US Army reported the use of pre-hospital REBOA in treating modern combat casualties [6]. After pre-hospital REBOA treatment, the patients were finally hemodynamically stabilized and safely evacuated without any apparent complications. Furthermore, the Russian Army have also validated the effectiveness of pre-hospital REBOA on the battlefield [7]. When combined with other resuscitation strategies like blood transfusion, pre-hospital REBOA can further enhance survival rates. Therefore, it is evident that pre-hospital REBOA is an effective method for acute care of massive hemorrhage and can be safely performed in the battlefield setting as an emergency treatment option for individuals at risk of cardiovascular failure due to injuries sustained in combat situations. On the battlefield, frontline implementation of REBOA allows temporary hemorrhage control and facilitates timely evacuation to the hospital, thereby reducing mortality rate and improving overall treatment outcomes, simultaneously saving lives among military personnel. This technology is of great significance for military applications and may become an essential skill for military training programs and medical practices in the future.</p><p>In addition to the battlefield environment, pre-hospital REBOA is also suitable for trauma patients in civilian conditions. Uncontrolled hemorrhagic shock or cardiac arrest accounts for a significant percentage of trauma patients. Some of these patients could benefit from pre-hospital REBOA. For patients severely injured from a high drop, REBOA serves as a safe and effective surgical technique that reduces blood loss and stabilizes the patient’s hemodynamic state, allows for longer transport times, and provides an opportunity for definitive hemostasis [8]. Pre-hospital REBOA uses a portable balloon catheter device to perform emergency bleeding control at the scene, rapidly controlling bleeding, maintaining hemodynamic stability, and providing resuscitative support to avoid death from hemorrhagic shock. Postoperative complications such as lower limb ischemia, organ ischemia–reperfusion injury, and aortic dissection occur less frequently. In the future, further standardized training platforms are needed to guide physicians to familiarize themselves with REBOA technology, indications, adverse reactions, and postoperative care.</p><p>In contrast to in-hospital conditions, REBOA performed in the grim pre-hospital environment requires a coordinated emergency health care system with a well-trained and -equipped care team. Given that battlefield or pre-hospital casualties often require evacuation, it is crucial to ensure the establishment of arterial access and successful placement of the arterial sheath. Successful REBOA placement has been reported on a rotary-wing platform [4]. Thus, it is recommended that eligible patients are promptly evacuated while performing REBOA en route during the evacuation period.</p><p>The prompt implementation of REBOA is crucial in the pre-hospital management of traumatic hemorrhage, emphasizing the necessity for expeditious surgical intervention. Previously, prior to initiating REBOA, ultrasonic or digital subtraction angiography should be performed. With improvements in catheterization devices and techniques, the competencies and successful rates of blind performance increased significantly, especially after comprehensive REBOA training. Following team training, the average time to complete the pre-hospital REBOA procedure under ultrasound guidance was 8.5 min [9]. Thus, standardized training and ample experience is imperative to ensure competency in pre-hospital REBOA. Given its favorable success rate, pre-hospital REBOA holds great appeal for both military and civilian conditions.</p><p>In conclusion, pre-hospital REBOA demonstrates promising potential as a temporary and minimally invasive bridge approach for eventual control of non-compressible traumatic hemorrhage. By occluding the aorta, REBOA effectively redistributes cardiac output to vital organs. As revealed so far, pre-hospital REBOA has shown favorable outcomes in controlling non-compressible torso hemorrhage (Fig. 1). The implementation of REBOA and its clinical training courses will improve the efficacy of pre-hospital treatment for life-threatening traumatic hemorrhages, ultimately reducing the loss of life caused by traumatic hemorrhage.</p><figure><figcaption><b data-test=\\\"figure-caption-text\\\">Fig. 1</b></figcaption><picture><source srcset=\\\"//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40779-023-00504-5/MediaObjects/40779_2023_504_Fig1_HTML.png?as=webp\\\" type=\\\"image/webp\\\"/><img alt=\\\"figure 1\\\" aria-describedby=\\\"Fig1\\\" height=\\\"640\\\" loading=\\\"lazy\\\" src=\\\"//media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40779-023-00504-5/MediaObjects/40779_2023_504_Fig1_HTML.png\\\" width=\\\"685\\\"/></picture><p>Pre-hospital application of resuscitative endovascular balloon occlusion of the aorta (REBOA) for life-threatening hemorrhage. Non-compressible traumatic hemorrhage could result in massive bleeding and hemorrhage shock. Pre-hospital utilization of REBOA could effectively stop persistent bleeding and prevent hemorrhage shock</p><span>Full size image</span><svg aria-hidden=\\\"true\\\" focusable=\\\"false\\\" height=\\\"16\\\" role=\\\"img\\\" width=\\\"16\\\"><use xlink:href=\\\"#icon-eds-i-chevron-right-small\\\" xmlns:xlink=\\\"http://www.w3.org/1999/xlink\\\"></use></svg></figure><p>Not applicable.</p><dl><dt style=\\\"min-width:50px;\\\"><dfn>REBOA:</dfn></dt><dd>\\n<p>Resuscitative endovascular balloon occlusion of the aorta</p>\\n</dd></dl><ol data-track-component=\\\"outbound reference\\\"><li data-counter=\\\"1.\\\"><p>Eastridge BJ, Holcomb JB, Shackelford S. Outcomes of traumatic hemorrhagic shock and the epidemiology of preventable death from injury. Transfusion. 2019;59(S2):1423–8.</p><p>Article PubMed Google Scholar </p></li><li data-counter=\\\"2.\\\"><p>Morrison JJ, Stannard A, Rasmussen TE, Jansen JO, Tai NRM, Midwinter MJ. Injury pattern and mortality of noncompressible torso hemorrhage in UK combat casualties. J Trauma Acute Care Surg. 2013;75(2 Suppl 2):S263–8.</p><p>Article PubMed Google Scholar </p></li><li data-counter=\\\"3.\\\"><p>Cralley AL, Vigneshwar N, Moore EE, Dubose J, Brenner ML, Sauaia A, et al. Zone 1 endovascular balloon occlusion of the aorta vs resuscitative thoracotomy for patient resuscitation after severe hemorrhagic shock. JAMA Surg. 2023;158(2):140–50.</p><p>Article PubMed Google Scholar </p></li><li data-counter=\\\"4.\\\"><p>Brown SR, Reed DH, Thomas P, Simpson C, Ritchie JD. Successful placement of REBOA in a rotary wing platform within a combat theater: novel indication for partial aortic occlusion. J Spec Oper Med. 2020;20(1):34–6.</p><p>Article PubMed Google Scholar </p></li><li data-counter=\\\"5.\\\"><p>Lendrum R, Perkins Z, Chana M, Marsden M, Davenport R, Grier G, et al. Pre-hospital resuscitative endovascular balloon occlusion of the aorta (REBOA) for exsanguinating pelvic haemorrhage. Resuscitation. 2019;135:6–13.</p><p>Article PubMed Google Scholar </p></li><li data-counter=\\\"6.\\\"><p>Glaser J, Teeter W, Gerlach T, Nathanial F. Resuscitative endovascular balloon occlusion of the aorta (REBOA) as an adjunct to damage control surgery for combat trauma: a case report of the first REBOA placed in Afghanistan. J Endovasc Resusc Tr. 2017;1(1):58–62.</p><p>Google Scholar </p></li><li data-counter=\\\"7.\\\"><p>Reva VA, Petrov AN, Samokhvalov IM. First Russian experience with endovascular balloon occlusion of the aorta in a zone of combat operations. Angiol Sosud Khir. 2020;26(2):61–75.</p><p>Article CAS PubMed Google Scholar </p></li><li data-counter=\\\"8.\\\"><p>Sadek S, Lockey DJ, Lendrum RA, Perkins Z, Price J, Davies GE. Resuscitative endovascular balloon occlusion of the aorta (REBOA) in the pre-hospital setting: an additional resuscitation option for uncontrolled catastrophic haemorrhage. Resuscitation. 2016;107:135–8.</p><p>Article PubMed Google Scholar </p></li><li data-counter=\\\"9.\\\"><p>Brede JR, Lafrenz T, Kruger AJ, Sovik E, Steffensen T, Kriesi C, et al. Resuscitative endovascular balloon occlusion of the aorta (REBOA) in non-traumatic out-of-hospital cardiac arrest: evaluation of an educational programme. BMJ Open. 2019;9(5):e027980.</p><p>Article PubMed PubMed Central Google Scholar </p></li></ol><p>Download references<svg aria-hidden=\\\"true\\\" focusable=\\\"false\\\" height=\\\"16\\\" role=\\\"img\\\" width=\\\"16\\\"><use xlink:href=\\\"#icon-eds-i-download-medium\\\" xmlns:xlink=\\\"http://www.w3.org/1999/xlink\\\"></use></svg></p><p>Not applicable.</p><p>Not applicable.</p><h3>Authors and Affiliations</h3><ol><li><p>Department of Interventional Radiology, Senior Department of Oncology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100039, China</p><p>Xiao-Mei Tian &amp; Feng-Yong Liu</p></li><li><p>Medical School of Chinese PLA, Beijing, 100853, China</p><p>Xiao-Mei Tian &amp; Feng-Yong Liu</p></li><li><p>Department of Emergency, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100039, China</p><p>Wei Hu</p></li><li><p>Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, 100039, China</p><p>Wei Hu</p></li></ol><span>Authors</span><ol><li><span>Xiao-Mei Tian</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Wei Hu</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li><li><span>Feng-Yong Liu</span>View author publications<p>You can also search for this author in <span>PubMed<span> </span>Google Scholar</span></p></li></ol><h3>Contributions</h3><p>FYL and WH conceived the study and supervised the work performed. XMT and WH wrote the manuscript. XMT and WH constructed the figure. FYL edited the manuscript and provided comments and feedback. All authors read and approved the final manuscript.</p><h3>Corresponding authors</h3><p>Correspondence to Wei Hu or Feng-Yong Liu.</p><h3>Ethics approval and consent to participate</h3>\\n<p>Not applicable.</p>\\n<h3>Consent for publication</h3>\\n<p>Not applicable.</p>\\n<h3>Competing interests</h3>\\n<p>The authors declare no competing interests.</p><p><b>Open Access</b> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</p>\\n<p>Reprints and Permissions</p><img alt=\\\"Check for updates. Verify currency and authenticity via CrossMark\\\" height=\\\"81\\\" src=\\\"data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg>\\\" width=\\\"57\\\"/><h3>Cite this article</h3><p>Tian, XM., Hu, W. &amp; Liu, FY. Pre-hospital application of REBOA for life-threatening hemorrhage. <i>Military Med Res</i> <b>10</b>, 65 (2023). https://doi.org/10.1186/s40779-023-00504-5</p><p>Download citation<svg aria-hidden=\\\"true\\\" focusable=\\\"false\\\" height=\\\"16\\\" role=\\\"img\\\" width=\\\"16\\\"><use xlink:href=\\\"#icon-eds-i-download-medium\\\" xmlns:xlink=\\\"http://www.w3.org/1999/xlink\\\"></use></svg></p><ul data-test=\\\"publication-history\\\"><li><p>Received<span>: </span><span><time datetime=\\\"2023-11-26\\\">26 November 2023</time></span></p></li><li><p>Accepted<span>: </span><span><time datetime=\\\"2023-12-02\\\">02 December 2023</time></span></p></li><li><p>Published<span>: </span><span><time datetime=\\\"2023-12-13\\\">13 December 2023</time></span></p></li><li><p>DOI</abbr><span>: </span><span>https://doi.org/10.1186/s40779-023-00504-5</span></p></li></ul><h3>Share this article</h3><p>Anyone you share the following link with will be able to read this content:</p><button data-track=\\\"click\\\" data-track-action=\\\"get shareable link\\\" data-track-external=\\\"\\\" data-track-label=\\\"button\\\" type=\\\"button\\\">Get shareable link</button><p>Sorry, a shareable link is not currently available for this article.</p><p data-track=\\\"click\\\" data-track-action=\\\"select share url\\\" data-track-label=\\\"button\\\"></p><button data-track=\\\"click\\\" data-track-action=\\\"copy share url\\\" data-track-external=\\\"\\\" data-track-label=\\\"button\\\" type=\\\"button\\\">Copy to clipboard</button><p> Provided by the Springer Nature SharedIt content-sharing initiative </p><h3>Keywords</h3><ul><li><span>Resuscitative endovascular balloon occlusion of the aorta (REBOA)</span></li><li><span>Pre-hospital</span></li><li><span>Endovascular</span></li><li><span>Aortic balloon occlusion</span></li><li><span>Trauma</span></li><li><span>Hemorrhage</span></li><li><span>Shock</span></li></ul>\",\"PeriodicalId\":18581,\"journal\":{\"name\":\"Military Medical Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":16.7000,\"publicationDate\":\"2023-12-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Military Medical Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s40779-023-00504-5\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Military Medical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s40779-023-00504-5","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

亲爱的编辑,大多数战场伤亡都发生在医疗设施到达之前。无法控制的大出血占战场上可能存活的伤亡人数的 90% 以上[1]。在军用和民用条件下,不可压缩的躯干大出血总是会导致快速失血,并在最终治疗前造成高死亡率[2]。超过一半的非可压缩性躯干大出血导致的死亡发生在医院救治之前[2]。因此,早期、快速的院前出血控制对于降低死亡率至关重要。主动脉血管内球囊闭塞复苏术(REBOA)是针对不可压缩性出血和严重失血性休克患者的一种挽救生命的手术[3]。除院内 REBOA 外,紧急 REBOA 也可在严峻的院前情况下为患者快速完成 [4]。因此,应用院前 REBOA 治疗危及生命的大出血越来越受到关注。及时接受院前 REBOA 治疗的患者,死亡率可降至 40% 以下[5]。在这封信中,我们重点讨论了在院前应用 REBOA 治疗危及生命的创伤性大出血在军事和民用环境中的应用。REBOA 由美国陆军在朝鲜战争中首次引入,用于治疗腹腔内出血。随着血管内设备和技术的重大改进,院前 REBOA 再次引起临床关注。最近,美国陆军报道了使用院前 REBOA 治疗现代作战伤员的情况[6]。经过院前 REBOA 治疗,患者最终血流动力学稳定并安全撤离,没有出现任何明显的并发症。此外,俄罗斯军队也验证了院前 REBOA 在战场上的有效性[7]。如果与输血等其他复苏策略相结合,院前 REBOA 还能进一步提高存活率。因此,院前 REBOA 显然是急性救治大出血的有效方法,可以在战场环境中安全实施,作为在战斗中受伤而面临心血管衰竭风险的人员的紧急治疗选择。在战场上,前线实施 REBOA 可暂时控制出血,便于及时送往医院,从而降低死亡率,改善整体治疗效果,同时挽救军人的生命。除了战场环境,院前 REBOA 也适用于民用环境下的创伤患者。无法控制的失血性休克或心脏骤停在创伤患者中占很大比例。其中一些患者可受益于院前 REBOA。对于因高空坠落而严重受伤的患者,REBOA 是一种安全有效的外科技术,可减少失血,稳定患者的血流动力学状态,延长转运时间,并提供明确止血的机会[8]。院前 REBOA 使用便携式球囊导管装置在现场进行紧急止血,可迅速控制出血、维持血流动力学稳定并提供复苏支持,避免因失血性休克而死亡。下肢缺血、器官缺血再灌注损伤、主动脉夹层等术后并发症发生率较低。与院内条件不同,在严峻的院前环境中实施 REBOA 需要一个协调的急诊医疗系统,以及一支训练有素、装备精良的护理团队。鉴于战场或院前伤员通常需要后送,确保建立动脉通路和成功放置动脉鞘至关重要。有报道称在旋转翼平台上可成功置入 REBOA [4]。因此,建议在后送期间及时后送符合条件的患者,同时在途中实施 REBOA。在创伤性出血的院前处理中,及时实施 REBOA 至关重要,强调了快速外科干预的必要性。以前,在启动 REBOA 之前,应进行超声波或数字减影血管造影。随着导管设备和技术的改进,盲法操作的能力和成功率显著提高,尤其是在接受了全面的 REBOA 培训之后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Pre-hospital application of REBOA for life-threatening hemorrhage

Dear Editor,

Most battlefield casualties occur prior to the arrival of medical facilities. Uncontrollable hemorrhage accounts for more than 90% of those potentially survivable battlefield casualties [1]. In both military and civilian conditions, non-compressible torso hemorrhage always caused rapid exsanguination and high mortality rates before definitive treatment [2]. More than half of the deaths due to non-compressible torso hemorrhage occur before hospital care can be provided [2]. Therefore, early and rapid pre-hospital hemorrhage control is essential to reduce mortality.

Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a life-saving procedure for patients with non-compressible hemorrhage and severe hemorrhagic shock [3]. In addition to in-hospital REBOA, urgent REBOA can be rapidly completed in grim pre-hospital situations for patients [4]. Thus, pre-hospital REBOA application for the treatment of life-threatening hemorrhages has attracted increasing attention. In patients who receive timely pre-hospital REBOA treatment, the mortality can be reduced to less than 40% [5]. In this letter, we focus on the pre-hospital application of REBOA for managing life-threatening traumatic hemorrhages in both military and civilian settings.

REBOA was first introduced by the US Army in the Korean War to treat intraabdominal hemorrhages. With significant improvements in endovascular equipment and techniques, pre-hospital REBOA has attracted renewed clinical interest. Recently, the US Army reported the use of pre-hospital REBOA in treating modern combat casualties [6]. After pre-hospital REBOA treatment, the patients were finally hemodynamically stabilized and safely evacuated without any apparent complications. Furthermore, the Russian Army have also validated the effectiveness of pre-hospital REBOA on the battlefield [7]. When combined with other resuscitation strategies like blood transfusion, pre-hospital REBOA can further enhance survival rates. Therefore, it is evident that pre-hospital REBOA is an effective method for acute care of massive hemorrhage and can be safely performed in the battlefield setting as an emergency treatment option for individuals at risk of cardiovascular failure due to injuries sustained in combat situations. On the battlefield, frontline implementation of REBOA allows temporary hemorrhage control and facilitates timely evacuation to the hospital, thereby reducing mortality rate and improving overall treatment outcomes, simultaneously saving lives among military personnel. This technology is of great significance for military applications and may become an essential skill for military training programs and medical practices in the future.

In addition to the battlefield environment, pre-hospital REBOA is also suitable for trauma patients in civilian conditions. Uncontrolled hemorrhagic shock or cardiac arrest accounts for a significant percentage of trauma patients. Some of these patients could benefit from pre-hospital REBOA. For patients severely injured from a high drop, REBOA serves as a safe and effective surgical technique that reduces blood loss and stabilizes the patient’s hemodynamic state, allows for longer transport times, and provides an opportunity for definitive hemostasis [8]. Pre-hospital REBOA uses a portable balloon catheter device to perform emergency bleeding control at the scene, rapidly controlling bleeding, maintaining hemodynamic stability, and providing resuscitative support to avoid death from hemorrhagic shock. Postoperative complications such as lower limb ischemia, organ ischemia–reperfusion injury, and aortic dissection occur less frequently. In the future, further standardized training platforms are needed to guide physicians to familiarize themselves with REBOA technology, indications, adverse reactions, and postoperative care.

In contrast to in-hospital conditions, REBOA performed in the grim pre-hospital environment requires a coordinated emergency health care system with a well-trained and -equipped care team. Given that battlefield or pre-hospital casualties often require evacuation, it is crucial to ensure the establishment of arterial access and successful placement of the arterial sheath. Successful REBOA placement has been reported on a rotary-wing platform [4]. Thus, it is recommended that eligible patients are promptly evacuated while performing REBOA en route during the evacuation period.

The prompt implementation of REBOA is crucial in the pre-hospital management of traumatic hemorrhage, emphasizing the necessity for expeditious surgical intervention. Previously, prior to initiating REBOA, ultrasonic or digital subtraction angiography should be performed. With improvements in catheterization devices and techniques, the competencies and successful rates of blind performance increased significantly, especially after comprehensive REBOA training. Following team training, the average time to complete the pre-hospital REBOA procedure under ultrasound guidance was 8.5 min [9]. Thus, standardized training and ample experience is imperative to ensure competency in pre-hospital REBOA. Given its favorable success rate, pre-hospital REBOA holds great appeal for both military and civilian conditions.

In conclusion, pre-hospital REBOA demonstrates promising potential as a temporary and minimally invasive bridge approach for eventual control of non-compressible traumatic hemorrhage. By occluding the aorta, REBOA effectively redistributes cardiac output to vital organs. As revealed so far, pre-hospital REBOA has shown favorable outcomes in controlling non-compressible torso hemorrhage (Fig. 1). The implementation of REBOA and its clinical training courses will improve the efficacy of pre-hospital treatment for life-threatening traumatic hemorrhages, ultimately reducing the loss of life caused by traumatic hemorrhage.

Fig. 1
figure 1

Pre-hospital application of resuscitative endovascular balloon occlusion of the aorta (REBOA) for life-threatening hemorrhage. Non-compressible traumatic hemorrhage could result in massive bleeding and hemorrhage shock. Pre-hospital utilization of REBOA could effectively stop persistent bleeding and prevent hemorrhage shock

Full size image

Not applicable.

REBOA:

Resuscitative endovascular balloon occlusion of the aorta

  1. Eastridge BJ, Holcomb JB, Shackelford S. Outcomes of traumatic hemorrhagic shock and the epidemiology of preventable death from injury. Transfusion. 2019;59(S2):1423–8.

    Article PubMed Google Scholar

  2. Morrison JJ, Stannard A, Rasmussen TE, Jansen JO, Tai NRM, Midwinter MJ. Injury pattern and mortality of noncompressible torso hemorrhage in UK combat casualties. J Trauma Acute Care Surg. 2013;75(2 Suppl 2):S263–8.

    Article PubMed Google Scholar

  3. Cralley AL, Vigneshwar N, Moore EE, Dubose J, Brenner ML, Sauaia A, et al. Zone 1 endovascular balloon occlusion of the aorta vs resuscitative thoracotomy for patient resuscitation after severe hemorrhagic shock. JAMA Surg. 2023;158(2):140–50.

    Article PubMed Google Scholar

  4. Brown SR, Reed DH, Thomas P, Simpson C, Ritchie JD. Successful placement of REBOA in a rotary wing platform within a combat theater: novel indication for partial aortic occlusion. J Spec Oper Med. 2020;20(1):34–6.

    Article PubMed Google Scholar

  5. Lendrum R, Perkins Z, Chana M, Marsden M, Davenport R, Grier G, et al. Pre-hospital resuscitative endovascular balloon occlusion of the aorta (REBOA) for exsanguinating pelvic haemorrhage. Resuscitation. 2019;135:6–13.

    Article PubMed Google Scholar

  6. Glaser J, Teeter W, Gerlach T, Nathanial F. Resuscitative endovascular balloon occlusion of the aorta (REBOA) as an adjunct to damage control surgery for combat trauma: a case report of the first REBOA placed in Afghanistan. J Endovasc Resusc Tr. 2017;1(1):58–62.

    Google Scholar

  7. Reva VA, Petrov AN, Samokhvalov IM. First Russian experience with endovascular balloon occlusion of the aorta in a zone of combat operations. Angiol Sosud Khir. 2020;26(2):61–75.

    Article CAS PubMed Google Scholar

  8. Sadek S, Lockey DJ, Lendrum RA, Perkins Z, Price J, Davies GE. Resuscitative endovascular balloon occlusion of the aorta (REBOA) in the pre-hospital setting: an additional resuscitation option for uncontrolled catastrophic haemorrhage. Resuscitation. 2016;107:135–8.

    Article PubMed Google Scholar

  9. Brede JR, Lafrenz T, Kruger AJ, Sovik E, Steffensen T, Kriesi C, et al. Resuscitative endovascular balloon occlusion of the aorta (REBOA) in non-traumatic out-of-hospital cardiac arrest: evaluation of an educational programme. BMJ Open. 2019;9(5):e027980.

    Article PubMed PubMed Central Google Scholar

Download references

Not applicable.

Not applicable.

Authors and Affiliations

  1. Department of Interventional Radiology, Senior Department of Oncology, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100039, China

    Xiao-Mei Tian & Feng-Yong Liu

  2. Medical School of Chinese PLA, Beijing, 100853, China

    Xiao-Mei Tian & Feng-Yong Liu

  3. Department of Emergency, the Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100039, China

    Wei Hu

  4. Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, 100039, China

    Wei Hu

Authors
  1. Xiao-Mei TianView author publications

    You can also search for this author in PubMed Google Scholar

  2. Wei HuView author publications

    You can also search for this author in PubMed Google Scholar

  3. Feng-Yong LiuView author publications

    You can also search for this author in PubMed Google Scholar

Contributions

FYL and WH conceived the study and supervised the work performed. XMT and WH wrote the manuscript. XMT and WH constructed the figure. FYL edited the manuscript and provided comments and feedback. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Wei Hu or Feng-Yong Liu.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tian, XM., Hu, W. & Liu, FY. Pre-hospital application of REBOA for life-threatening hemorrhage. Military Med Res 10, 65 (2023). https://doi.org/10.1186/s40779-023-00504-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40779-023-00504-5

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • Resuscitative endovascular balloon occlusion of the aorta (REBOA)
  • Pre-hospital
  • Endovascular
  • Aortic balloon occlusion
  • Trauma
  • Hemorrhage
  • Shock
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Military Medical Research
Military Medical Research Medicine-General Medicine
CiteScore
38.40
自引率
2.80%
发文量
485
审稿时长
8 weeks
期刊介绍: Military Medical Research is an open-access, peer-reviewed journal that aims to share the most up-to-date evidence and innovative discoveries in a wide range of fields, including basic and clinical sciences, translational research, precision medicine, emerging interdisciplinary subjects, and advanced technologies. Our primary focus is on modern military medicine; however, we also encourage submissions from other related areas. This includes, but is not limited to, basic medical research with the potential for translation into practice, as well as clinical research that could impact medical care both in times of warfare and during peacetime military operations.
期刊最新文献
International Alliance of Urolithiasis (IAU) consensus on miniaturized percutaneous nephrolithotomy. Mechanism of lactic acidemia-promoted pulmonary endothelial cells death in sepsis: role for CIRP-ZBP1-PANoptosis pathway. Microenvironment-responsive nanomedicines: a promising direction for tissue regeneration. Cardiovascular adaptations and pathological changes induced by spaceflight: from cellular mechanisms to organ-level impacts. Sexual dimorphism in the relationship between BMI and recent suicidal attempts in first-episode drug-naïve patients with major depressive disorder.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1